CTLA4 and neoplasm: Since both mAbs showed comparable immunotherapeutic effect and comparable depletion of Treg cells in the tumor microenvironment,10 local depletion of Treg cells, rather than blockade of the mB7-CTLA-4 interaction, provides a unifying explanation for the therapeutic effect of anti-mouse CTLA-4 mAbs.